Enhancing Transgender Breast Cancer Screening: A Call for More Inclusive Research

Current Gaps in Transgender Breast Cancer Screening Research

Recent findings published in the Journal of the American College of Radiology reveal significant gaps in research regarding breast cancer screening for transgender individuals. The study, led by Millie Chokshi of the University of Miami, highlights that while existing data shows mixed outcomes, transgender populations generally exhibit lower breast cancer screening rates compared to their cisgender counterparts. This discrepancy underscores the need for more comprehensive studies to develop methods that ensure equitable access to preventive healthcare for transgender and gender-diverse individuals.

Implications of Limited Data on Clinical Practices

The majority of existing research on transgender breast cancer screening is derived from studies outside of the United States, primarily from Germany. This lack of localized data is concerning as it hampers the ability to tailor federal health guidelines and clinical recommendations effectively. Chokshi’s team stresses the importance of expanding research efforts to fill this knowledge gap, which is crucial for informing healthcare practices that adequately address the specific needs of the transgender community.

Advancing Research for Better Health Outcomes

The review conducted by Chokshi and her colleagues analyzed data from 12 studies conducted between 2015 and 2023, which included participants undergoing hormone treatments or who had top-level surgery. Their findings indicated that transfeminine individuals, in particular, were less likely to undergo recommended breast cancer screenings compared to cisgender women. This research highlights the urgent need for targeted studies that not only address the disparities in screening rates but also work towards closing the gender-biased research gap. By enhancing the recruitment and reporting of transgender and gender-diverse individuals in cancer screening studies, researchers can better support the development of clinical guidelines and improve healthcare outcomes for these communities.